MyFinsight
Home
Blog
About
Back
Income Statement
Allogene Therapeutics, Inc. (ALLO)
Allogene Therapeutics, Inc. (ALLO)
source: myfinsight.com
Net comprehensive
loss
-$43,012,000
(15.71%↑ Y/Y)
Interest and other
income, net
$4,647,000
(-24.89%↓ Y/Y)
Net loss
-$42,677,000
(16.23%↑ Y/Y)
Net unrealized gain
(loss) on...
-$335,000
(-280.68%↓ Y/Y)
Total other income
(expenses), net
$4,243,000
(-27.79%↓ Y/Y)
Interest expense
$343,000
(27.99%↑ Y/Y)
Other income
(expenses), net
-$61,000
(-41.86%↓ Y/Y)
Loss from operations
-$46,920,000
(17.42%↑ Y/Y)
Collaboration revenue -
related party
$4,640,000
Total operating
expenses
$51,560,000
(-9.26%↓ Y/Y)
Research and development
$30,721,000
(-23.50%↓ Y/Y)
General and
administrative
$20,839,000
(45.92%↑ Y/Y)
Back